Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors.

MLA

Xing, Yan, and Donna E. Hogge. “Combined Inhibition of the Phosphoinosityl-3-Kinase (PI3Kinase) P110δ Subunit and Mitogen-Extracellular Activated Protein Kinase (MEKinase) Shows Synergistic Cytotoxicity against Human Acute Myeloid Leukemia Progenitors.” Leukemia Research, vol. 37, no. 6, June 2013, pp. 697–704. EBSCOhost, https://doi.org/10.1016/j.leukres.2013.03.003.

APA

Xing, Y., & Hogge, D. E. (2013). Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors. Leukemia Research, 37(6), 697–704. https://doi.org/10.1016/j.leukres.2013.03.003

Chicago

Xing, Yan, and Donna E Hogge. 2013. “Combined Inhibition of the Phosphoinosityl-3-Kinase (PI3Kinase) P110δ Subunit and Mitogen-Extracellular Activated Protein Kinase (MEKinase) Shows Synergistic Cytotoxicity against Human Acute Myeloid Leukemia Progenitors.” Leukemia Research 37 (6): 697–704. doi:10.1016/j.leukres.2013.03.003.